This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Bisoprolol Fumarate

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20220726

Version

1

Spl Product Data Elements

Bisoprolol Fumarate Bisoprolol Fumarate BISOPROLOL FUMARATE BISOPROLOL ALUMINUM OXIDE ANHYDROUS DIBASIC CALCIUM PHOSPHATE BUTYLATED HYDROXYANISOLE CROSPOVIDONE (12 MPA.S AT 5%) D&C YELLOW NO. 10 ALUMINUM LAKE FD&C RED NO. 40 HYPROMELLOSE 2910 (6 MPA.S) MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 6000 SILICON DIOXIDE TITANIUM DIOXIDE light pink to pink 111 Bisoprolol Fumarate Bisoprolol Fumarate BISOPROLOL FUMARATE BISOPROLOL ANHYDROUS DIBASIC CALCIUM PHOSPHATE BUTYLATED HYDROXYANISOLE CROSPOVIDONE (12 MPA.S AT 5%) HYPROMELLOSE 2910 (6 MPA.S) MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 6000 SILICON DIOXIDE TITANIUM DIOXIDE white to off white colored with occasional greyish 112

Application Number

ANDA215680

Brand Name

Bisoprolol Fumarate

Generic Name

Bisoprolol Fumarate

Product Ndc

70771-1727

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1726-3 Bisoprolol Fumarate Tablets USP, 5 mg 30 Tablets Unit-of-Use Rx only NDC 70771-1727-3 Bisoprolol Fumarate Tablets USP, 10 mg 30 Tablets Unit-of-Use Rx only 5 mg label 10 mg label

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.